Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combigan vs Simbrinza as Add-on to Latanoprost in Glaucoma
NCT02167035Phase 4Completed
- Sponsor
- Cornerstone Health Care
- Start
- Aug 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine tartrate + timolol maleate in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Cornerstone Health Care. Started Aug 2014; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02167035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167035.